Publications by authors named "Marc Esser"

Claim this Profile
H
Health-related quality of life (HRQoL) in German early benefit assessment: The importance of disease-specific instruments.
Lisa Kramer, Malte Moos, Bastian Thaa, Robert Welte, Marc Esser

Z Evid Fortbild Qual Gesundhwes· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.
Falko M Heinemann, Peter T Jindra, Clemens L Bockmeyer, Philip Zeuschner, Juliane Wittig

Sci Rep· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for mRNA analysis of micro-dissected glomerular tufts from paraffin-embedded human kidney biopsy samples.
Clemens L Bockmeyer, Juliane Wittig, Karen Säuberlich, Philipp Selhausen, Marc Eßer

BMC Mol Biol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.
Falko M Heinemann, Peter T Jindra, Clemens L Bockmeyer, Philip Zeuschner, Juliane Wittig

Sci Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated first-principles mapping for phase-change materials.
Marc Esser, Stefan Maintz, Richard Dronskowski

J Comput Chem· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of different normalization strategies for the analysis of glomerular microRNAs in IgA nephropathy.
Clemens L Bockmeyer, Karen Säuberlich, Juliane Wittig, Marc Eßer, Sebastian S Roeder

Sci Rep· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
Michael V Knopp, Thomas Balzer, Marc Esser, Franciska K Kashanian, Predip Paul

Invest Radiol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluations of granulocyte colony-stimulating factor: in the prevention and treatment of chemotherapy-induced neutropenia.
Marc Esser, Helmut Brunner

Pharmacoeconomics· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis